These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 28369730)
1. Genetics of hypertrophic cardiomyopathy: A review of current state. Sabater-Molina M; Pérez-Sánchez I; Hernández Del Rincón JP; Gimeno JR Clin Genet; 2018 Jan; 93(1):3-14. PubMed ID: 28369730 [TBL] [Abstract][Full Text] [Related]
2. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Marian AJ Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503 [TBL] [Abstract][Full Text] [Related]
5. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. Maron BJ; Maron MS; Semsarian C J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258 [TBL] [Abstract][Full Text] [Related]
6. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. Maron BJ; Maron MS; Semsarian C Heart Rhythm; 2012 Jan; 9(1):57-63. PubMed ID: 21839045 [TBL] [Abstract][Full Text] [Related]
7. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting. Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739 [TBL] [Abstract][Full Text] [Related]
8. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy. Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161 [TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594 [TBL] [Abstract][Full Text] [Related]
10. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Gruner C; Care M; Siminovitch K; Moravsky G; Wigle ED; Woo A; Rakowski H Circ Cardiovasc Genet; 2011 Jun; 4(3):288-95. PubMed ID: 21511876 [TBL] [Abstract][Full Text] [Related]
11. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review. Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395 [TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605 [TBL] [Abstract][Full Text] [Related]
13. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life. Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977 [TBL] [Abstract][Full Text] [Related]
14. Sarcomere variants in arrhythmogenic cardiomyopathy: Pathogenic factor or bystander? Chen K; Rao M; Guo G; Chen X; Chen L; Song J Gene; 2019 Mar; 687():82-89. PubMed ID: 30385303 [TBL] [Abstract][Full Text] [Related]
15. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations. Lopes LR; Rahman MS; Elliott PM Heart; 2013 Dec; 99(24):1800-11. PubMed ID: 23674365 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Bos JM; Will ML; Gersh BJ; Kruisselbrink TM; Ommen SR; Ackerman MJ Mayo Clin Proc; 2014 Jun; 89(6):727-37. PubMed ID: 24793961 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028 [TBL] [Abstract][Full Text] [Related]